| Patents for A61P 5 - Drugs for disorders of the endocrine system (28,908) |
|---|
| 08/23/2007 | US20070197547 4-(1-piperazinyl)-2(1H)-quinolone and 4-(1-piperazinyl)quinoline derivatives, e.g., 4-(1-piperazinyl)-1-methyl-3-nitro-2(1H)-quinolone |
| 08/23/2007 | US20070197527 Bicyclic heteroaromatic compounds |
| 08/23/2007 | US20070197510 Nitriles and medicinal compositions containing the same as the active ingredient |
| 08/23/2007 | US20070197489 Composition of matter |
| 08/23/2007 | US20070196883 Enzyme |
| 08/23/2007 | US20070196857 Determination of risk and treatment of complications of prematurity |
| 08/23/2007 | DE102007008231A1 Pharmazeutische Zubereitung zur Behandlung der Migräne A pharmaceutical preparation for the treatment of migraine |
| 08/23/2007 | DE102005062417A1 Kompositionen mit spezifischen und unspezifischen Lipidantagonisten Compositions with specific and nonspecific lipid antagonists |
| 08/23/2007 | CA2642205A1 Bicyclic imidazole or thiadiazole heterocycles useful as selective androgen receptor modulators |
| 08/23/2007 | CA2636617A1 Novel aminoalcohol-substituted aryldihydroisoquinolinones, process for their preparation and their use as medicaments |
| 08/22/2007 | EP1820494A2 Microspheres of estradiol and cholesterol |
| 08/22/2007 | EP1572892A4 Human glucagon-like-peptide-1 mimics and their use in the treatment of diabetes and related conditions |
| 08/22/2007 | EP1476470B1 Starch derivatives, starch active substance conjugates, method for the production thereof and their use as medicaments |
| 08/22/2007 | EP1351673B1 Compositions of stable t3 and use thereof |
| 08/22/2007 | EP0925069B1 Use of cetrorelix for the treatment of benign prostate hypertrophy and prostate cancer |
| 08/22/2007 | CN1332974C Nevol anti-estrogenic steroids, and associated pharmaceutical compositions and method of use |
| 08/22/2007 | CN1332711C Method for administering GLP-1 molecules |
| 08/22/2007 | CN101022818A 生理活性的组合物 The composition of the physiologically active |
| 08/21/2007 | US7259179 Kinase inhibitors |
| 08/21/2007 | US7258855 Culturing a transformant in a medium, allowing the polypeptide having phospholipase a2 activity fo form and accumulating in the culture, recovering the polypeptide thus formed |
| 08/16/2007 | WO2007092727A1 Novel imidazolopyrazole derivatives useful as selective androgen receptor modulators |
| 08/16/2007 | WO2007092400A1 Aminophenyl derivatives as selective androgen receptor modulators |
| 08/16/2007 | WO2007091396A1 Novel amidopropionic acid derivative and pharmaceutical product containing same |
| 08/16/2007 | WO2007068948A3 Pharmaceutical sustained release compositions comprising in particular thyroid hormones |
| 08/16/2007 | WO2006121684A3 Acyl hydrazones for treating cardiovascular diseases |
| 08/16/2007 | WO2006116526A8 Polymorph form ii of tanaproget |
| 08/16/2007 | WO2005037260A3 Use of adrenergic alphaze antagonists for the treatment of vasomotor symptoms |
| 08/16/2007 | US20070191592 amidated peptide; stress-related conditions |
| 08/16/2007 | US20070191435 Hydrochloride salt of 5-[4-[2-(n-methyl-n-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione |
| 08/16/2007 | US20070191403 e.g. 3-[{hydroxycarbonylpropyl-amino}-2-phenylethyl]-5-(2-fluoro-3-methoxyphenyl)-1-[2-fluoro-6-(trifluoromethyl)benzyl]-6-methylpyrimidine-2,4(1H,3H)-dione; sex-hormone related diseases; anticarcinogenic agent; endometriosis, uterine fibroids, polycystic ovarian disease |
| 08/16/2007 | US20070191402 Method of searching substrate having antidiabetic activity |
| 08/16/2007 | US20070190120 Administration of non-oral androgenic steroids to women |
| 08/16/2007 | US20070190054 Prevention and treatment of complement-associated disorders |
| 08/16/2007 | CA2642154A1 Novel imidazolopyrazole derivatives useful as selective androgen receptor modulators |
| 08/15/2007 | EP1656360B1 Thiazoline derivatives as selective androgen receptor modulators (sarms) |
| 08/15/2007 | EP1467974B1 Benzimidazole derivatives and their use as gnrh antagonists |
| 08/15/2007 | EP1343488B1 Treatment of statin side effects |
| 08/15/2007 | EP1292568B1 Benzamide ligands for the thyroid receptor |
| 08/15/2007 | CN1331862C Di-aryl acid derivatives as PPAR receptor ligands |
| 08/15/2007 | CN1331860C Protein tyrosine phosphatase 1B inhibitor gamma-butyrolactones compounds and their preparation process and use |
| 08/15/2007 | CN1331848C Tricyclic steroid hormone nuclear receptor modulators |
| 08/15/2007 | CN1331463C Method for chemo-prevention of prostate cancer |
| 08/14/2007 | US7256199 2-(Substituted amino)-6-(4-pyridyl)pyrimidin-4-ones, e.g., 2-(N-phenylamino)-6-(4-pyridyl)pyrimidin-4-one and 2-(N-(3-bromophenyl)amino)-6-(4-pyridyl)pyrimidin-4-one; treatment of diseases caused by tau protein kinase 1 hyperactivity such as Alzheimer disease. |
| 08/14/2007 | US7256188 3-aminoalkyl-2-aryl-indole derivatives and their use as GnRH antagonists |
| 08/14/2007 | US7255879 Extracting and recovering embryonic-like stem cells, including pluripotent or multipotent stem cells, from an exsanguinated human placenta; use of the isolated and perfused placenta as a bioreactor in which to propagate endogenous/exogenous cells |
| 08/14/2007 | CA2421302C 4-halogenated 17-methylene steroids, method for the production thereof and pharmaceutical compositions containing these compounds |
| 08/09/2007 | WO2007088681A1 Ghrelin production promoter |
| 08/09/2007 | WO2007054809A3 Antagonist antibodies directed against calcitonin gene-related peptide and methods using same |
| 08/09/2007 | WO2007054269A3 Extracts from the bark of corynanthe species, use thereof, and medicaments, dietary products, and pharmaceutical preparations containing said extracts |
| 08/09/2007 | WO2007031140A3 Extracts from epimedium species method for production and use thereof |
| 08/09/2007 | WO2007024338A3 3 -ester prodrugs of ethynylestradiol |
| 08/09/2007 | WO2006072600A8 Androstane 17-alpha-carbonate for use in the treatment of inflammatory and allergic conditions |
| 08/09/2007 | US20070184091 Animal feed composition |
| 08/09/2007 | US20070184064 Chimeric peptide immunogens |
| 08/09/2007 | DE10066158B4 Verwendung eines transdermalen therapeutischen Systems zur Behandlung des Restless-Legs-Syndroms Use of a transdermal therapeutic system for the treatment of Restless Legs Syndrome |
| 08/08/2007 | EP1816136A1 Gpr7-selective ligand and use thereof |
| 08/08/2007 | EP1815867A1 Combination drug for treating autoimmune disease |
| 08/08/2007 | EP1815860A2 Phosphate transport inhibitors |
| 08/08/2007 | EP1360169B1 Succinate salt of o-desmethyl-venlafaxine |
| 08/08/2007 | EP1357870B1 Bioadhesive cell foam film of sustained-release delivery |
| 08/08/2007 | EP1347979B1 Indole derivatives and their use as 5-ht2b and 5-ht2c receptor ligands |
| 08/08/2007 | CN1330641C Activator for peroxisome proliferator-responsive receptor delta |
| 08/08/2007 | CN1330640C Substituted bicyclic derivatives for the treatment of abnormal cell growth |
| 08/08/2007 | CN1330633C Pyrrolidine derivatives as oxytocin antagonists |
| 08/08/2007 | CN1330300C Pharmaceutical compositions |
| 08/08/2007 | CN1330296C Propolis soft capsule and its preparation method |
| 08/08/2007 | CN101014610A 15beta-substituted steroids having selective estrogenic activity |
| 08/08/2007 | CN101011095A Megranate tea and its preparing process |
| 08/07/2007 | US7253284 Chemical compounds |
| 08/07/2007 | US7253203 Indoline derivatives |
| 08/07/2007 | US7253199 Azole derivatives and pharmaceutical compositions containing them |
| 08/07/2007 | US7253187 Heterocyclic inhibitors of ERK2 and uses thereof |
| 08/07/2007 | US7253172 Enzyme inhibitor for treating a non-insulin dependent diabetes mellitus; 3-Amino-4-(3,4-difluorophenyl)butanoyl]-4-[2-({3-[(methylsulfonyl)amino]-phenyl}-amino)-2-oxoethyl]piperazin-2-yl}acetic acid |
| 08/07/2007 | US7253156 E.g., budesonide dodecylcarbonate and budesonide 2-dimethylaminoethyl carbonatewith agonists such as albuterol, formoterol, or salmeterol; used for inducing bronchodilation and treating COPD, asthma and rhinitis. |
| 08/07/2007 | US7252974 Human growth gene and short stature gene region |
| 08/07/2007 | CA2263904C Process to obtain oestrogens from mare's urine |
| 08/07/2007 | CA2239702C Oligopeptide compounds containing d-2-alkyltryptophan capable of promoting the release of growth hormone |
| 08/07/2007 | CA2151563C Preparation of stable zinc insulin analog crystals |
| 08/07/2007 | CA2124801C Gonadotropin containing pharmaceutical compositions with sucrose stabilizer |
| 08/02/2007 | WO2007086565A1 Growth hormone secretion regulator |
| 08/02/2007 | WO2007086545A1 Method for screening cell function regulator |
| 08/02/2007 | WO2007086471A1 Process for production of lasofoxifene or analogue thereof |
| 08/02/2007 | WO2007017423A3 Pharmaceutical composition comprising a dpp-iv inhibitor |
| 08/02/2007 | US20070179297 Chemical compounds |
| 08/02/2007 | US20070179099 Methods of cholesterol reduction using isoflavones |
| 08/02/2007 | US20070179097 GnRH agonist combination drugs |
| 08/02/2007 | CA2823751A1 Methods and compositions for treating feline hyperthyroidism |
| 08/01/2007 | EP1812559A1 A method for differentiation of pancreatic stem cells into insulin producing cells |
| 08/01/2007 | EP1812417A1 Novel 2h-chromene derivatives as selective estrogen receptor modulators |
| 08/01/2007 | EP1812406A2 Novel benzimidazole derivatives useful as selective androgen receptor modulators (sarms) |
| 08/01/2007 | EP1812404A1 Indazoles, benzisoxazoles and benzisothiazoles and their use as estrogenic agents |
| 08/01/2007 | EP1487822B1 Pyrrole-2,5-dione derivatives and their use as gsk-3 inhibitors |
| 08/01/2007 | EP1461038B1 Arylsulfonamide derivatives for use as ccr3 antagonists in the treatment of inflammatory and immunological disorders |
| 08/01/2007 | EP1330468B1 Sulphur analogues of 21-hydroxy-6,19-oxidoprogesterone (21oh-6op) for treating excess of glucocorticoids |
| 08/01/2007 | CN1329394C Novel imidazole derivatives, production method thereof and use thereof |
| 08/01/2007 | CN101010074A Use of a selective estrogen receptor modulator for the manufacture of a pharmaceutical preparation for use in a method for the treatment or prevention of androgen deficiency |
| 08/01/2007 | CN101007803A Piperazinyl-, piperidinyl- and morpholinyl-derivatives as novel inhibitors of histone deacetylase |
| 08/01/2007 | CN101007085A A drug for treating hyperthyroidism and its preparation method |
| 08/01/2007 | CN101007001A Therapeutic methods and compositions involving isoflavones |
| 08/01/2007 | CN101007000A Therapeutic methods and compositions involving isoflavones |